Cited by 1,619Healthcare Policy and ManagementChronic Disease Management StrategiesHealth Systems, Economic Evaluations, Quality of Life

Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018

Open access
Peery, Anne F., Crockett, Seth D., Murphy, Caitlin C., Lund, Jennifer L., Dellon, Evan S., Williams, J. Lucas, Jensen, Elizabeth T., Shaheen, Nicholas J. +9 more·2019·Gastroenterology

Abstract

Background & aims Estimates of disease burden can inform national health priorities for research, clinical care, and policy. We aimed to estimate health care use and spending among gastrointestinal (GI) (including luminal, liver, and pancreatic) diseases in the United States.Methods We estimated health care use and spending based on the most currently available administrative claims from commercial and Medicare Supplemental plans, data from the GI Quality Improvement Consortium Registry, and national databases.Results In 2015, annual health care expenditures for gastrointestinal diseases totaled $135.9 billion. Hepatitis ($23.3 billion), esophageal disorders ($18.1 billion), biliary tract disease ($10.3 billion), abdominal pain ($10.2 billion), and inflammatory bowel disease ($7.2 billion) were the most expensive. Yearly, there were more than 54.4 million ambulatory visits with a primary diagnosis for a GI disease, 3.0 million hospital admissions, and 540,500 all-cause 30-day readmissions. There were 266,600 new cases of GI cancers diagnosed and 144,300 cancer deaths. Each year, there were 97,700 deaths from non-malignant GI diseases. An estimated 11.0 million colonoscopies, 6.1 million upper endoscopies, 313,000 flexible sigmoidoscopies, 178,400 upper endoscopic ultrasound examinations, and 169,500 endoscopic retrograde cholangiopancreatography procedures were performed annually. Among average-risk persons aged 50-75 years who underwent colonoscopy, 34.6% had 1 or more adenomatous polyps, 4.7% had 1 or more advanced adenomatous polyps, and 5.7% had 1 or more serrated polyps removed.Conclusions GI diseases contribute substantially to health care use in the United States. Total expenditures for GI diseases are $135.9 billion annually-greater than for other common diseases. Expenditures are likely to continue increasing.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2018.08.063

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [9]Gonzalez JM. National Health Care Expenses in the U.S. Civilian Noninstitutionalized Population, 2011. Statistical Brief (Medical Expenditure Panel Survey (US)) Rockville (MD), 2001. 29708697
  2. [10]Carroll W, Miller GE. Heart Disease among Elderly Americans: Estimates for the U.S. Civilian Noninstitutionalized Population, 2010. Statistical Brief (Medical Expenditure Panel Survey (US)) Rockville (MD), 2001. 29638303
  3. [38]Lin J, Piper M, Perdue L, Screening for colorectal cancer: an updated systematic review for the USPSTF. AHRQ, 14 (2015), pp. 1– 240.

Cited by

Sorted by citations

Authors
Peery, A. F., Crockett, S. D., Murphy, C. C., Lund, J. L., Dellon, E. S., Williams, J. L., Jensen, E. T., Shaheen, N. J., Barritt, A. S., Lieber, S. R., Kochar, B., Barnes, E. L., Fan, Y. C., Pate, V., Galanko, J., Baron, T. H., & Sandler, R. S.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • The University of Texas Southwestern Medical Center (US)
  • Wake Forest University Health Sciences (US)
Corresponding author
Peery, Anne F.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2019-01
Volume
156
Issue
1
Pages
254-272.e11
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2897031692
Cited by
1,619
References
39
Citations by year
2026: 87 · 2025: 174 · 2024: 217 · 2023: 245 · 2022: 272 · 2021: 287 · 2020: 228 · 2019: 101 · 2018: 3 · 2017: 1 · 2013: 1 · 2012: 1
FWCI
41.40
Type
journal article
Language
en
Update notices
erratum (2019-05-01)
Open access
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
Funders
National Institutes of Health (K23DK113225, KL2TR001103, KL2TR001109, T32 DK07634)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
  • Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
gastrointestinal diseases, liver disease, pancreatic diseases, health care expenditure, disease burden, health care utilization, hospitalization, 30-day readmission, gastrointestinal cancer, hepatitis, esophageal diseases, biliary tract diseases, abdominal pain, inflammatory bowel disease, colonoscopy, adenomatous polyps, serrated polyps, endoscopy
MeSH terms
Adolescent, Adult, Aged, Health Expenditures, Female, Gastrointestinal Diseases, Health Services Needs and Demand, Humans, Liver Diseases, Male, Middle Aged, Pancreatic Diseases, Socioeconomic Factors, Time Factors, United States, Incidence, Prevalence, Health Care Costs, Cost of Illness, Needs Assessment, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review